GlassScriptPhysician profile
Jason W Levine
NPI 1427046507
$5,203.64
in general payments reported to CMS, 2019-2025
22 companies · $148 in 2025
The $148 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
See the full distribution for Sports Medicine (Orthopaedic Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,156 · 2020: $636 · 2021: $178 · 2022: $2,610 · 2023: $211 · 2024: $264 · 2025: $148.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $624.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $623.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rock Medical Orthopedics, INC. | $2,452.46 | 2021-2022 | |
| Smith+Nephew, INC. | $1,738.21 | 2019-2025 | Na, Mini-Open Latarjet, Spatial Frame |
| Zimmer Biomet Holdings, INC. | $201.77 | 2019-2025 | Tapestry, Persona |
| Tricoast Surgical Solutions LLC | $132.21 | 2023 | |
| Stryker Corporation | $117.94 | 2022-2024 | Mako, Aequalis Ascend Flex |
| Medtronic USA, INC. | $108.13 | 2019 | |
| Vericel Corporation | $87.24 | 2019 | |
| Bioventus LLC | $79.58 | 2021-2025 | Durolane |
| Takeda Pharmaceuticals U.S.A., INC. | $57.82 | 2020-2022 | |
| Depuy Synthes Sales INC. | $23.82 | 2024 | Gii, Dynatape, Dynacord |
| Davol INC. | $21.72 | 2021 | |
| Medtronic, INC. | $19.82 | 2022 | |
| Anika Therapeutics, INC. | $19.54 | 2023 | Ovomotion |
| Sanofi-Aventis U.S. LLC | $19.08 | 2022 | |
| Horizon Therapeutics Plc | $18.06 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $16.75 | 2024 | Wegovy |
| Acumed LLC | $16.24 | 2023 | Acumed |
| Integra Lifesciences Corporation | $16.00 | 2019 | |
| Convatec INC. | $15.78 | 2025 | |
| Si-Bone, INC. | $15.14 | 2022 | |
| Abbvie INC. | $14.41 | 2019 | |
| Supernus Pharmaceuticals, INC. | $11.92 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Levine listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.